✦ LIBER ✦

Superiority of Enoxaparin Over Heparin in Combination With a GPIIb/IIIa Receptor Antagonist During Coronary Thrombolysis in Dogs

✍ Scribed by Sam S Rebello; Charles J Kasiewski; Ross G Bentley; Suzanne R Morgan; Valeria Chu; Jeffrey S Bostwick; Scott I Klein; Mark H Perrone; Robert J Leadley

Book ID: 117257019
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 202 KB
Volume: 102
Category: Article
ISSN: 0049-3848
DOI: 10.1016/s0049-3848(01)00242-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evidence of platelet activation during t

Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes

✍ Dermot Cox; Richard Smith; Martin Quinn; Pierre Theroux; Peter Crean; Desmond J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Restoration of coronary blood flow by si

Restoration of coronary blood flow by single bolus injection of the gpiib/iiia receptor antagonist c7e3 fab in a patient with acute myocardial infarction of recent onset

✍ Hans Domanovits; Karin Janata; Anton N. Laggner; Stephan Hornykewycz; Mariam Nik 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB

9 Effect of the selective thromboxane re

9 Effect of the selective thromboxane receptor antagonist (TRA) 8M 13.177 on coronary thrombolysis in a dog model and in patients with acute myocardial infarction (AMI)

✍ Shebuski, R.J.; van Erckelens, K.; Uebis, R.; Etti, H.; Kondor, P. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 145 KB

EFFECTS OF GLYCOPROTEIN IIB/IIIA INHIBIT

EFFECTS OF GLYCOPROTEIN IIB/IIIA INHIBITORS IN COMBINATION WITH VORAPAXAR, A PLATELET THROMBIN-RECEPTOR ANTAGONIST, AMONG PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE TRACER TRIAL

✍ Cornel, J.H.; Tricoci, Pierluigi; Horton, john; Moliterno, David; Wallentin, Lar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 146 KB

711-3-A Multicenter, Randomized, Double-

711-3-A Multicenter, Randomized, Double-Blind Pilot Trial of Standard Versus Low Dose Weight-Adjusted Heparin in Patients Treated with the Platelet GP IIb/IIIa Receptor Antibody c7E3 During Percutaneous Coronary Revascularization

✍ A. Michael Lincoff; James E. Tcheng; Theodore A. Bass; Jeffrey J. Popma; Paul S. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 237 KB